FDA News Digest August 12, 2002 _________________________________________ Colorectal Cancer Drug Approved on 'Fast Track' After its fastest review yet for a cancer drug, FDA has approved the colorectal cancer drug Eloxatin (oxaliplatin). Used in combination with other cancer drugs, the drug was shown to shrink tumors in some patients and delay resumed tumor growth. http://www.fda.gov/bbs/topics/NEWS/2002/NEW00825.html _______________________________________________ FDA Scientist Named First 'Americas Fellow' Andreas Keller, Ph.D., an expert in microbiology, will serve as the United States' first "Americas Fellow" under a new exchange program with democracies throughout the Western Hemisphere. The Americas Fellows Exchange Program was initiated by President Bush and strongly supported by HHS Secretary Tommy G. Thompson to promote excellence in government. Keller will work with the Mexican government on Good Agricultural and Manufacturing Practices and imported produce safety initiatives. http://www.hhs.gov/news/press/2002pres/20020731e.html ________________________________________________ Food Biotechnology Meeting to be Held Aug. 13-14 The Food Biotechnology Subcommittee of FDA's Food Advisory Committee will discuss whether new proteins in bioengineered foods are likely to cause allergic reactions in some individuals. Feedback from this meeting will help FDA prepare draft guidance for industry. http://www.fda.gov/OHRMS/DOCKETS/98fr/072502d.htm _________________________________________________ Food Labeling Workshop Slated for Aug. 14-15 in Dallas FDA will hold a public workshop about regulations on food labeling and allergen declaration, along with other related matters of importance to regulated industry, particularly small businesses and startups. http://www.cfsan.fda.gov/~dms/wh-alrgy.html#dallas _________________________________________________ Ear, Nose, and Throat Devices Panel to Meet Aug. 16 The Ear, Nose, and Throat Devices Panel of FDA's Medical Devices Advisory Committee will meet in Gaithersburg, Md., to discuss and make recommendations on a draft guidance on implantable middle ear hearing devices. http://www.fda.gov/OHRMS/DOCKETS/98fr/072502e.htm _________________________________________________ Thanks for subscribing to the FDA News Digest. Our next posting will be August 19. To leave this list at any time, send an e-mail to LISTSERV@LIST.NIH.GOV In the body of the message, write SIGNOFF FDA-NEWSDIGEST-L
